Fourteen-Year Anti-TNF Therapy in Crohn’s Disease Patients: Clinical Characteristics and Predictive Factors

被引：0
作者：
Aisaku Osamura
Yasuo Suzuki
机构：
[1] Toho University,Department of Internal Medicine, Sakura Medical Center
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
Crohn’s disease; Loss of response; Infliximab; Adalimumab; Risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：204 / 208
页数：4
相关论文
共 50 条
  • [41] Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients
    Strik, Anne S.
    Lowenberg, Mark
    Buskens, Christianne J.
    Gecse, Krisztina B.
    Ponsioen, Cyriel, I
    Bemelman, Willem A.
    D'Haens, Geert R.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (04) : 453 - 458
  • [42] The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
    Kassouri, Liza
    Amiot, Aurelien
    Kirchgesner, Julien
    Treton, Xavier
    Allez, Mathieu
    Bouhnik, Yoram
    Beaugerie, Laurent
    Carbonnel, Franck
    Meyer, Antoine
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (10) : 1148 - 1155
  • [43] Increased arterial stiffness in Crohn's disease: Prevalence, associated factors and impact of anti-TNF therapy
    Fissah, Mahrez
    Rechach, Adel
    Charifi, Meriem
    Menzou, Farouk
    Taharboucht, Said
    Djouhri, Messaouda
    Talbi, Leila
    Touati, Nadia
    Atif, Lamine
    Rabhia, Mehdi
    Chibane, Ahcene
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2025, 48 (01):
  • [44] The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease
    Haennig, A.
    Staumont, G.
    Lepage, B.
    Faure, P.
    Alric, L.
    Buscail, L.
    Bournet, B.
    Moreau, J.
    COLORECTAL DISEASE, 2015, 17 (04) : 311 - 319
  • [45] Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications
    Baert, FJ
    Rutgeerts, PR
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1999, 14 (01) : 47 - 51
  • [46] Disease Duration Did Not Influence the Rates of Loss of Efficacy of the Anti-TNF Therapy in Latin American Crohn's Disease Patients
    Kotze, Paulo Gustavo
    Ludvig, Juliano Coelho
    Teixeira, Fabio Vieira
    Malluta, Everson Fernando
    Miranda, Eron Fabio
    Hardt, Marcelo Raisweiler
    Olandoski, Marcia
    da Silva Kotze, Lorete Maria
    Kleinubing, Harry, Jr.
    DIGESTION, 2015, 91 (02) : 158 - 163
  • [47] Azathioprine and anti-TNFα therapies in Crohn's disease:: a review of pharmacology, clinical efficacy and safety
    Arnott, IDR
    Watts, D
    Satsangi, J
    PHARMACOLOGICAL RESEARCH, 2003, 47 (01) : 1 - 10
  • [48] Surgery for Crohn's disease and anti-TNF agents: the changing scenario
    Sorrentino, Dario
    Fogel, Sandy
    Van den Bogaerde, Johan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (08) : 689 - 700
  • [49] Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease
    Wright, Emily K.
    Kamm, Michael A.
    De Cruz, Peter
    Hamilton, Amy L.
    Selvaraj, Fabiyola
    Princen, Fred
    Gorelik, Alexandra
    Liew, Danny
    Prideaux, Lani
    Lawrance, Ian C.
    Andrews, Jane M.
    Bampton, Peter A.
    Jakobovits, Simon L.
    Florin, Timothy H.
    Gibson, Peter R.
    Debinski, Henry
    Macrae, Finlay A.
    Samuel, Douglas
    Kronborg, Ian
    Radford-Smith, Graham
    Gearry, Richard B.
    Selby, Warwick
    Bell, Sally J.
    Brown, Steven J.
    Connell, William R.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (06) : 653 - 661
  • [50] Outcomes of Perianal Fistulising Crohn's Disease Following Anti-TNFα Treatment Discontinuation
    Legue, Clemence
    Brochard, Charlene
    Bessi, Gregoire
    Wallenhorst, Timothee
    Dewitte, Marie
    Siproudhis, Laurent
    Bouguen, Guillaume
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (06) : 1107 - 1113
12345